Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy Ac

Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy Ac

Item

http://www.wikidata.org/entity/Q36036395

Q36036395

about

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention ABCB1 C3435T polymorphism and response to clopidogrel treatment in coronary artery disease (CAD) patients: a meta-analysis Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease.The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban).

P2860

Q33426570-9F2A696D-0452-4C62-B64F-138186040779 Q34441355-3BC81DB4-6DCE-44EE-B0A8-FD6E9809A62E Q38734885-4DAA77A7-70F8-4498-BC20-E5D9E0A51C45 Q38750444-8DB2B1A5-CEE2-41D9-B6CE-BF8810633B6B

P2860

Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy Ac

Item

http://www.wikidata.org/entity/Q36036395

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Interaction analysis between g ...... Triple Antiplatelet Therapy Ac

@ast

Interaction analysis between g ...... Triple Antiplatelet Therapy Ac

@en

type

Item

label

Interaction analysis between g ...... Triple Antiplatelet Therapy Ac

@ast

Interaction analysis between g ...... Triple Antiplatelet Therapy Ac

@en

prefLabel

Interaction analysis between g ...... Triple Antiplatelet Therapy Ac

@ast

Interaction analysis between g ...... Triple Antiplatelet Therapy Ac

@en

P1476

Interaction analysis between g ...... ng to Gene Polymorphism) study

@en

P2093

Eun-Ha Koh

http://www.w3.org/2001/XMLSchema#string

In-Suk Kim

http://www.w3.org/2001/XMLSchema#string

Jeong Rang Park

http://www.w3.org/2001/XMLSchema#string

Jin-Yong Hwang

http://www.w3.org/2001/XMLSchema#string

Seok-Jae Hwang

http://www.w3.org/2001/XMLSchema#string

Seong-Eun Yoon

http://www.w3.org/2001/XMLSchema#string

Sunjoo Kim

http://www.w3.org/2001/XMLSchema#string

Tae Jung Kwon

http://www.w3.org/2001/XMLSchema#string

Yongwhi Park

http://www.w3.org/2001/XMLSchema#string

Young-Hoon Jeong

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Coronary stent restenosis in patients treated with cilostazol

Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis

Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data.

Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1.

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis

Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.

Genetic determinants of response to clopidogrel and cardiovascular events.

P304

629-640

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2011.04131.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Choong Hwan Kwak

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51728246

http://www.w3.org/2001/XMLSchema#string

P698

22007612

http://www.w3.org/2001/XMLSchema#string

P932

3376439

http://www.w3.org/2001/XMLSchema#string

Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy Ac

about

P2860

P2860

Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy Ac

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932